The Role of Acute Hyperglycemia on the Risk of Malignant Arrhythmia in Acute Myocardial Infarction Patients: A Study of Myocardial Damage, Ion Channel Changes and Inflammatory Factors

Sally Aman Nasution, Idrus Alwi, Imam Subekti, M Yamin, Suhendro Suhendro, Kuntjoro Harimurti, Suzanna Immanuel, Abdul Majid, Esther Elizabeth, Chairul N Azali


Background: acute myocardial infarction (AMI) is often followed by hyperglycemia. To date, there is no study that examine the role of myocardial damage, ion channel changes and increased inflammatory response as a pathomechanism of malignant arrhythmias due to hyperglycemia in AMI patients. The aim of this study is to determine the effect of acute hyperglycemia on the occurence of malignant arrhythmias, troponin I, VLP, echocardiographic strain, ion channel changes (CaMKII) and hsCRP. This study also aims to assess the effect of troponin I, VLP, GLS, CaMKII and hsCRP on the occurence of malignant arrhythmias in AMI patients with acute hyperglycemia. Methods: a cross-sectional study followed by a cohort study was conducted on AMI patients treated at ICCU Cipto Mangunkusumo Hospital Jakarta during November 2018 to May 2019 period. Patients with severe infections and who had experienced malignant arrhythmias at admission were excluded from the study. The occurence of malignant arrhythmias as the main outcome of this study and CaMKII level were assessed on the fifth day of treatment. Patients who died before the fifth day of treatment due to causes other than malignant arrhythmias were excluded from analysis. The association between acute hyperglycemia with VLP and the occurence of malignant arrhythmias was analyzed through a chi-square test, whereas the differences between troponin I, GLS, CaMKII and hsCRP, based on the hyperglycemia status of the patient, were analyzed by Mann-Whitney U test. Results: a total of 110 patients were included in the study. Two patients died on the third day of observation due to malignant arrhythmias. No significant relationship was found between acute hyperglycemia in AMI and malignant arrhythmias (RR = 1,38, 95%CI 0.50−3.77). There were differences of CaMKII level on day-1 and day-5 between those who were experienced malignant arrhytmia and those who were not (p-value for differences are 0,03 and 0,01, respectively. In the acute hyperglycemia group, there was difference of CaMKII day-5 levels between positive and negative VLP (p = 0.03). Conclusion: it was concluded that the inititial stage of AMI causes more dominant myocardial damage, as compared to metabolic factors. In the next stage of AMI, acute hyperglycemia increases ROS and the activation of ion channel changes described by CaMKII. This change results in electrophysiological remodeling of the heart, as seen in the VLP image on SA-ECG.


acute hyperglycemia; AMI; CaMKII; hsCRP; malignant arrhythmias; VLP


Zein AFM, Nasution SA, Purnamasari D, Mansjoer A. The influence of hyperglycemia at admission on in-hospital arrhythmia patients with acute coronary syndrome. Acta Med Indones. 2015;47(4).

Underwood D, Jaeger F, Simmons T, editors. The effect of varying filter techniques on late potential parameters of signal averaged electrocardiographic records. [1991] Proceedings Computers in Cardiology; 1991: IEEE.

Eryol NK, Topsakal R, Oguzhan A, et al. Is the change of late potential over time related to enzyme levels? Ichemic burden in acute myocardial infarction. J Annals Noninvasive Electrocardiol. 2002;7(3):242-6.

Zhang P. CaMKII: The molecular villain that aggravates cardiovascular disease. J Experimental Ther Med. 2017;13(3):815-20.

Erickson JR, Pereira L, Wang L, et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. J Nature. 2013;502(7471):372.

Marfella R, Siniscalchi M, Esposito K, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. J Diabetes care. 2003;26(11):3129-35.

Mountantonakis S, Deo R. Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac death. J Cardiovascular Therapeutics. 2012;30(2):e74-e80.

Empana J-P, Jouven X, Canouï-Poitrine F, et al. C-reactive protein, interleukin 6, fibrinogen and risk of sudden death in European middle-aged men: the PRIME study. J Arteriosclerosis Thromb Vasc Biol. 2010;30(10):2047-52.

Angeli F, Reboldi G, Poltronieri C, et al. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. J Ther Advan Cardiovascular Dis. 2015;9(6):412-24.

Kaneko H, Anzai T, Naito K, et al. Role of ischemic preconditioning and inflammatory response in the development of malignant ventricular arrhythmias after reperfused ST-elevation myocardial infarction. J Cardiac Failure. 2009;15(9):775-81.

Full Text: PDF


  • There are currently no refbacks.